🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
More than 150,000 babies became infected with HIV in 2015 alone. When HIV d...
Status
Completed
Location
St. Monica's Hospital
Start Date
2017-12-22
Trial ID
NCT03284645
The goal of this clinical study is to provide continued access to the study...
Status
Recruiting
Location
Helios Salud
Start Date
2024-08-27
Trial ID
NCT06337032
Treatments Being Tested
The primary objective of this study in antiretroviral (ARV)-naïve Human imm...
Status
Terminated
Location
Multiple Locations
Start Date
2012-07-31
Trial ID
NCT01620944
Treatments Being Tested
The purpose of this trial is to assess the non-inferior antiviral activity ...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-02-01
Trial ID
NCT01263015
The purpose of this trial is to assess the non-inferior antiviral activity ...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-10-19
Trial ID
NCT01227824
Treatments Being Tested
Single-arm, multi-center, Phase I/II clinical trial, in two groups. Individ...
Status
Active Not Recruiting
Location
The Aurum Institute: Pretoria Clinical Research Centre
Start Date
2023-05-24
Trial ID
NCT05122767
Treatments Being Tested
The primary objective of this study is to evaluate the efficacy of switchin...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2018-08-28
Trial ID
NCT03631732
Treatments Being Tested
Single-arm, single-center, Phase I/II clinical trial, in four groups. Indiv...
Status
Completed
Location
The Aurum Institute: Tembisa Clinical Research Centre
Start Date
2018-01-18
Trial ID
NCT03435146
Treatments Being Tested
BACKGROUND: Since 1996 the combination of three or more drugs has been the ...
Status
Completed
Location
Centro de Tratamento Ambulatoria do Hospital Nacional Simão Mendes
Start Date
2011-05
Trial ID
NCT01192035
Treatments Being Tested
Maraviroc (UK-427,857), a selective and reversible CCR5 coreceptor antagoni...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2004-11
Trial ID
NCT00098293